CFTR and hereditary disease: As variant-specific treatment options become increasingly available for genetic disorders involving membrane proteins (e.g., the Cystic Fibrosis Transmembrane Conductance Regulator [CFTR]), this information has the potential to be leveraged in future therapy for individuals harboring particular variants.